Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial

JT Merrill, CM Neuwelt, DJ Wallace, JC Shanahan, KM Latinis, JC Oates, TO Utset, Caroline Gordon, DA Isenberg, HJ Hsieh, D Zhang, PG Brunetta

Research output: Contribution to journal › Article

830 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences